Vicadrostat by Boehringer Ingelheim International for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval

Vicadrostat is under clinical development by Boehringer Ingelheim International and currently in Phase III for Chronic Kidney Disease (Chronic Renal Failure).

Brain-computer interfaces are rapidly evolving. Here are six scientists shaping the field

Nearly 20 years after neuroscientist John Donoghue placed electrodes on Matthew Nagle’s motor cortex, allowing the man with no limb movement to control objects using

October 3, 2024

Bintrafusp alfa by Merck for Head And Neck Cancer Squamous Cell Carcinoma: Likelihood of Approval – Pharmaceutical Technology

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 27, 2023

Mediterranean diet boosts quality of life—here’s how

A systematic review finds that following the Mediterranean diet is linked to better physical, mental, and social well-being, particularly in aging populations and those with

February 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.